Every material Form 8-K Healthcare Services Group filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Healthcare Services Group reported third-quarter 2025 revenue of $464.3 million, up 8.5% from the prior year, and net income of $43.0 million, or $0.59 per diluted share, compared with $14.0 million, or $0.19, a year earlier. The filing says the results include a $0.36 per share benefit, primarily from the Employee Retention Credit, partly offset by a previously announced Genesis charge, so the profit gain is not all from operations.
Revenue of $464.3 million for the three months ended September 30, 2025, up 8.5% from the prior year
Net income of $43.0 million and diluted EPS of $0.59, including a $0.36 per share benefit primarily related to the Employee Retention Credit
Cash flow from operations of $71.3 million, including a $31.8 million Employee Retention Credit benefit
Share repurchases of $27.3 million in the quarter under a $50.0 million plan running through June 2026
Healthcare Services Group reported second-quarter revenue of $458.5 million, up 7.6% from a year earlier, but posted a net loss of $32.4 million, or $0.44 per diluted share, compared with a net loss of $1.8 million a year earlier. The loss includes a $0.65 per share non-cash charge tied to the previously announced Genesis HealthCare restructuring. The company raised its 2025 cash flow from operations forecast, excluding the change in payroll accrual, and announced a $50.0 million share repurchase plan over the next 12 months.
Revenue of $458.5 million for the three months ended June 30, 2025, up 7.6% over the prior year
Net loss of $32.4 million, or $0.44 per diluted share, including a $0.65 per share non-cash Genesis restructuring charge ($61.2 million pretax)
2025 cash flow from operations forecast, excluding payroll accrual changes, raised to $70.0 to $85.0 million from $60.0 to $75.0 million
Board-authorized plan to repurchase $50.0 million of common stock over 12 months; $7.6 million repurchased in the second quarter
Healthcare Services Group reported first-quarter 2025 revenue of $447.7 million, up 5.7% from the prior year, with net income of $17.2 million, or $0.23 per diluted share, versus $15.3 million, or $0.21, a year earlier. The company raised its 2025 cash flow from operations forecast (excluding the change in payroll accrual) to $60.0 million to $75.0 million from $45.0 million to $60.0 million, while reiterating mid-single digit revenue growth expectations.
Revenue of $447.7 million, up from $423.4 million in the first quarter of 2024
Net income of $17.2 million and diluted EPS of $0.23, compared with $15.3 million and $0.21 a year earlier
Cash flow from operations excluding payroll accrual change of $32.1 million, versus a negative $9.2 million a year earlier
2025 cash flow from operations forecast raised to $60.0 million to $75.0 million; company repurchased about $7.0 million of stock in the quarter
Healthcare Services Group reported fourth-quarter 2024 revenue of $437.8 million, up from $423.8 million a year earlier, but net income fell to $11.9 million from $23.5 million, with diluted EPS of $0.16 versus $0.32. The company guided to mid-single digit revenue growth in 2025 and first-quarter 2025 revenue of $440.0 to $450.0 million, which gives shareholders a near-term outlook alongside a sharp drop in quarterly profit.
Q4 2024 revenue was $437.8 million versus $423.8 million in Q4 2023; net income was $11.9 million versus $23.5 million, inclusive of new business start-up costs.
Full-year 2024 revenue was $1.72 billion versus $1.67 billion in 2023; full-year diluted EPS was $0.53 versus $0.52.
2025 outlook: mid-single digit revenue growth, Q1 2025 revenue of $440.0 to $450.0 million, and cash flow from operations excluding the payroll accrual change of $45.0 to $60.0 million.
Cash and marketable securities were $135.8 million at year-end, and the company has repurchased over $16.0 million of stock since February 2023.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Healthcare Services Group filing is on SEC EDGAR ↗. 8-K briefs of other companies →